Global Information
회사소개 | 문의 | 비교리스트

컨슈머 헬스케어(CHC) 연감 : 2022년

CHC YearBook 2022

리서치사 Nicholas Hall & Company
발행일 2022년 04월 상품코드 1043365
페이지 정보 영문 301 Pages 배송안내
가격
£ 8,750 ₩ 13,997,000 PDF (Site License)
£ 13,600 ₩ 21,756,000 PDF (Global License)


컨슈머 헬스케어(CHC) 연감 : 2022년 CHC YearBook 2022
발행일 : 2022년 04월 페이지 정보 : 영문 301 Pages

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 컨슈머 헬스케어(CHC: Consumer Healthcare) 시장에 대해 조사했으며, 시장 개요, 지역별 동향, 주요 시장, 카테고리별 동향, 주요 기업 동향, 주요 브랜드, 처방약에서 OTC 의약품으로의 전환과 업계 발전 동향 등에 대해 전해드립니다.

목차

컨슈머 헬스케어(CHC) 시장의 정의

제1장 세계 리뷰

제2장 지역별 리뷰

  • 북미
  • 동아시아 및 동남아시아
  • 서유럽
  • 중유럽 및 동유럽
  • 일본
  • 라틴아메리카
  • 인도아대륙
  • 오스트랄라시아

제3장 주요 시장

  • 미국
  • 중국
  • 일본
  • 독일
  • 프랑스
  • 이탈리아
  • 브라질
  • 인도
  • 러시아
  • 영국
  • 호주
  • 캐나다
  • 폴란드
  • 한국
  • 인도네시아

제4장 카테고리별 리뷰

  • 진통제
  • 기침/감기/알레르기
  • 위장
  • 비타민/미네랄/보충제
  • 피부과
  • 라이프스타일 컨슈머 헬스케어(CHC)

제5장 대기업

  • GlaxoSmithKline
  • Johnson & Johnson
  • Bayer
  • Sanofi
  • Reckitt
  • Procter & Gamble
  • Taisho
  • China Resources 999
  • Nestlé
  • Stada
  • Prestige Consumer Healthcare
  • Otsuka
  • Abbott
  • Teva
  • Bausch Health
  • Viatris
  • Mondelez
  • Church & Dwight
  • Perrigo
  • Dong-e E-jiao Group

제6장 합병과 인수

제7장 주요 브랜드

제8장 핫토픽

제9장 처방약에서 OTC 의약품으로의 전환

  • 개요
  • 서유럽
  • 북미
  • 일본
  • 오스트랄라시아
  • 신흥 시장
  • 대규모 전환

제10장 신제품 개발과 혁신

  • 진통제
  • 기침/감기/알레르기
  • 위장
  • 비타민/미네랄/보충제
  • 피부과
  • 라이프스타일 컨슈머 헬스케어(CHC)

제11장 세계의 소매

  • 시장 현황
  • 자사 브랜드와 제네릭
  • 주요 소매업체
  • 세계 소매의 미래

제12장 기업의 소유권

제13장 브랜드와 마케터

제14장 제조업체 협회

제15장 용어집

LSH 22.05.10

CHC FACTS & FIGURES IN FOCUS

THE ESSENTIAL GUIDE IN TODAY'S CHALLENGING MARKETS

  • CHC category analysis
  • Company & brand profiles
  • Mergers, acquisitions & joint-ventures
  • Rx-to-OTC Switch
  • Hot Topics
  • New Product Development & Innovation
  • Global, regional & country coverage
  • Latest year-end data from DB6

A vital resource for Consumer Health marketers, offering instant access to the key facts & figures needed to support quick and accurate decision-making, including full year-end 2021 sales data from the only dedicated worldwide CHC sales database.

Expanded coverage - New for 2022

“CHC YearBook 2022” edition includes

All channels data for the total CHC market, including splits for Store, Direct Internet & mail order sales. Selected chapters will feature added detail of sales Direct (MLM) and Internet & mail order channels, reflecting the latest information from our dedicated “DB6” database.

“CHC YearBook” is used by top OTC, pharma and consumer health companies, investment banks and consultants around the world.

Depending on your requirements, the report is available in various digital licences (Site or Global) or as individual print copies.

With extensive knowledge and experience in benchmarking the world of consumer health, Nicholas Hall's “CHC YearBook 2022” provides a focused set of data and analysis. Find all the facts, all the figures, at your fingertips.

Global Review

  • Highlighting major developments and global trends, and forecasting the CHC outlook for the future

Regional Review

  • 8 major regions come under the spotlight, with the focus on key markets, trends and developments

Leading Markets

  • Coverage of the Top 15 markets includes topline data by category, leading marketers and brands - PLUS a country-by-country review of regulations, switch environment, advertising and distribution

Category Review

  • Global coverage of Analgesics, CCA, Gastrointestinals, VMS, Derma and Lifestyle CHC

Leading Companies

  • Profiles of the Top 20 CHC players across the world.
  • Leading 250 CHC marketers by sales with CAGR 2017-21

Mergers & Acquisitions

  • All the major M&A activity, joint-ventures and alliances since 2017 - PLUS coverage of multiples paid for acquisitions in the CHC industry

Leading Brands

  • The leading 250 CHC brands by sales - PLUS concise profiles of the Top 25 brands

Hot Topics

  • Analysis of the latest hot-button issues affecting consumer health, such as personalisation, sustainability and Covid's impact on CHC.

Rx-to-OTC Switch

  • Overview of the switch environment in key markets - PLUS profiles of significant Rx-to-OTC switches

New Product Development & Innovation

  • Overview of latest activity in delivery formats and NPD across CHC categories.

Global Retailing

  • Comprehensive overview of the fast-changing global retailing environment - PLUS major retailer profiles

Essential Reference Tables

  • Information on classification of ingredients, company ownership, brands & marketers and manufacturers' associations - PLUS a CHC glossary

Table of Contents

CHC Market Definition

1. Global Review

  • World Overview
  • Competitive Landscape
  • Switch
  • Brands & Innovation
  • Retailing
  • Outlook

2. Regional Review

  • North America
  • East & South East Asia
  • Western Europe
  • Central & Eastern Europe
  • Japan
  • Latin America
  • Indian Subcontinent
  • Australasia

3. Leading Markets

  • USA
  • China
  • Japan
  • Germany
  • France
  • Italy
  • Brazil
  • India
  • Russia
  • UK
  • Australia
  • Canada
  • Poland
  • South Korea
  • Indonesia

4. Category Review

  • Analgesics
  • Cough, cold & allergy
  • Gastrointestinals
  • Vitamins, minerals & supplements
  • Dermatologicals
  • Lifestyle CHC

5. Leading Companies

  • GlaxoSmithKline
  • Johnson & Johnson
  • Bayer
  • Sanofi
  • Reckitt
  • Procter & Gamble
  • Taisho
  • China Resources 999
  • Nestlé
  • Stada
  • Prestige Consumer Healthcare
  • Otsuka
  • Abbott
  • Teva
  • Bausch Health
  • Viatris
  • Mondelez
  • Church & Dwight
  • Perrigo
  • Dong-e E-jiao Group

6. Mergers & Acquisitions

7. Leading Brands

  • Vicks
  • Tylenol
  • Voltaren
  • Advil
  • Nature Made
  • Centrum
  • Nicorette
  • Panadol
  • Halls
  • Dong-e E-Jiao
  • Nature's Bounty
  • Mucinex
  • Claritin
  • Zyrtec
  • Yunnan Baiyao
  • Doliprane
  • Caltrate
  • Allegra
  • Olly
  • Nurofen
  • 999 Gan Mao Ling
  • Bayer Aspirin
  • Reneed
  • Strepsils
  • By-Health

8. Hot Topics

  • Personalisation still a notable trend in consumer health NPD
  • Consumers increasingly seeing benefits of home testing and e-Health services
  • Femtech puts women in charge of their healthcare outcomes
  • Sustainability & transparency remain targets for investment in CHC

9. Rx-to-OTC Switch

  • Overview
  • Western Europe
  • North America
  • Japan
  • Australasia
  • Emerging markets
  • The Big Switches
    • Allegra
    • Alli, Xenical
    • Claritin
    • Differin
    • ellaOne
    • Flonase / Flixonase
    • Formigran
    • Hana, Lovima
    • Loxonin S
    • Maloff Protect
    • MiraLAX
    • Mucinex
    • Nasacort
    • Nexium 24HR
    • Plan B, NorLevo, Postinor, Levonelle
    • Prevacid 24HR
    • Prilosec OTC
    • Rhinocort
    • Silvasta, MaxOn Active / Tadalafil MaxOn, Viagra Connect
    • Volini
    • Voltaren
    • Zyrtec

10. New Product Development & Innovation

  • Analgesics
  • Cough, cold & allergy
  • Gastrointestinals
  • Vitamins, minerals & supplements
  • Dermatologicals
  • Lifestyle CHC

11. Global Retailing

  • Market snapshots
  • Private Labels & Generics
  • The major retail players
  • The Future of Global Retailing

12. Company Ownership

13. Brands & Marketers

14. Manufacturers' Associations

15. Glossary

Charts

  • Chart 1: Global CHC sales by region 2021
  • Chart 2: Global CHC sales by category 2021
  • Chart 3: Global CHC forecasts by region
  • Chart 4: Global CHC forecasts by category
  • Chart 5: North America CHC market by category 2021
  • Chart 6: North America leading CHC marketers & brands 2021
  • Chart 7: E&SE Asia CHC market by category 2021
  • Chart 8: E&SE Asia leading CHC marketers & brands 2021
  • Chart 9: Western Europe CHC market by category 2021
  • Chart 10: Western Europe leading CHC marketers & brands 2021
  • Chart 11: C&E Europe CHC market by category 2021
  • Chart 12: C&E Europe leading CHC marketers & brands 2021
  • Chart 13: Japan CHC market by category 2021
  • Chart 14: Japan leading CHC marketers & brands 2021
  • Chart 15: Latin America CHC market by category 2021
  • Chart 16: Latin America leading CHC marketers & brands 2021
  • Chart 17: Indian Subcontinent CHC market by category 2021
  • Chart 18: Indian Subcontinent leading CHC marketers & brands
  • Chart 19: Australasia CHC market by category 2021
  • Chart 20: Australasia leading CHC marketers & brands 2021
  • Chart 21: Global leading 15 CHC markets 2021
  • Chart 22: USA CHC market by category 2021
  • Chart 23: USA leading CHC marketers & brands 2021
  • Chart 24: China CHC market by category 2021
  • Chart 25: China leading CHC marketers & brands 2021
  • Chart 26: Japan CHC market by category 2021
  • Chart 27: Japan leading CHC marketers & brands 2021
  • Chart 28: Germany CHC market by category 2021
  • Chart 29: Germany leading CHC marketers & brands 2021
  • Chart 30: France CHC market by category 2021
  • Chart 31: France leading CHC marketers & brands 2021
  • Chart 32: Italy CHC market by category 2021
  • Chart 33: Italy leading CHC marketers & brands 2021
  • Chart 34: Brazil CHC market by category 2021
  • Chart 35: Brazil leading CHC marketers & brands 2021
  • Chart 36: India CHC market by category 2021
  • Chart 37: India leading CHC marketers & brands 2021
  • Chart 38: Russia CHC market by category 2021
  • Chart 39: Russia leading CHC marketers & brands 2021
  • Chart 40: UK CHC market by category 2021
  • Chart 41: UK leading CHC marketers & brands 2021
  • Chart 42: Australia CHC market by category 2021
  • Chart 43: Australia leading CHC marketers & brands 2021
  • Chart 44: Canada CHC market by category 2021
  • Chart 45: Canada leading CHC marketers & brands 2021
  • Chart 46: Poland CHC market by category 2021
  • Chart 47: Poland leading CHC marketers & brands 2021
  • Chart 48: South Korea CHC market by category 2021
  • Chart 49: South Korea leading CHC marketers & brands 2021
  • Chart 50: Indonesia CHC market by category 2021
  • Chart 51: Indonesia leading CHC marketers & brands 2021
  • Chart 52: Global CHC analgesics category split 2021
  • Chart 53: Leading analgesic brands 2021
  • Chart 54: Global CHC CCA category split 2021
  • Chart 55: Leading CCA brands 2021
  • Chart 56: Global CHC GIs category split 2021
  • Chart 57: Leading GI brands 2021
  • Chart 58: Global CHC VMS category split 2021
  • Chart 59: Leading VMS brands 2021
  • Chart 60: Global CHC dermatologicals category split 2021
  • Chart 61: Leading dermatological brands 2021
  • Chart 62: Global lifestyle CHC category split 2021
  • Chart 63: Leading lifestyle CHC brands 2021
  • Chart 64: Top 250 CHC marketers 2021
  • Chart 65: CHC merger, acquisition, alliance & joint-venture activity 2017-2022
  • Chart 66: Multiples paid for CHC acquisitions 2016-2022
  • Chart 67: Leading CHC brands 2021
  • Chart 68: Legal status of ingredients in selected world markets
  • Chart 69: Legal status of ingredients in selected European markets (I)
  • Chart 70: Legal status of ingredients in selected European markets (II)
  • Chart 71: Big Switches global CHC sales 2021
  • Chart 72: Company Ownership Index
  • Chart 73: Brands & Marketers Index
Back to Top
전화 문의
F A Q